PHSA - BCC - PHARM - Hematologic Adverse Effects

After completing this course learners will be able to:

  • Understand the pathophysiology of myelosuppression.
  • Review the methods for grading myelosuppression.
  • Describe the prevention, assessment and management of neutropenia and febrile neutropenia.
  • Describe the prevention, assessment and management of thrombocytopenia.
  • Describe the prevention, assessment and management of anemia.
  • Describe the prevention, identification, and management of other hematologic side effects.
  • Categorize cancer therapy agents commonly associated with hematologic toxicities.

Pharmacists at BC Cancer

3 hrs 30 mins
5753

Contact Info

Mandeep Bains

mkbains@bccancer.bc.ca

For technical issues, please submit a ticket through LearningHub Help Site.